GCP
CRMD icon

GSA Capital Partners’s CorMedix CRMD Stock Holding History

GSA Capital Partners’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,825
Closed -$96K – 1672
2024
Q3 		$96K Sell
11,825
-30,294
-72% -$164K 0.01% 1493
2024
Q2 		$182K Buy
+42,119
New +$214K 0.01% 1472
2024
Q1 		– Sell
-24,721
Closed -$93K – 1668
2023
Q4 		$93K Buy
+24,721
New +$85.1K 0.01% 1400
2023
Q3 		– Sell
-38,311
Closed -$152K – 1551
2023
Q2 		$152K Sell
38,311
-42,330
-52% -$209K 0.02% 1334
2023
Q1 		$334K Sell
80,641
-55,915
-41% -$229K 0.03% 962
2022
Q4 		$576K Buy
136,556
+114,951
+532% +$407K 0.07% 517
2022
Q3 		$61K Buy
21,605
+3,056
+16% +$12.7K 0.01% 1407
2022
Q2 		$75K Sell
18,549
-29,473
-61% -$110K 0.01% 1255
2022
Q1 		$263K Buy
48,022
+13,469
+39% +$61.7K 0.04% 990
2021
Q4 		$157K Buy
34,553
+21,710
+169% +$108K 0.02% 1265
2021
Q3 		$60K Sell
12,843
-654
-5% -$3.81K 0.01% 1343
2021
Q2 		$93K Sell
13,497
-1,131
-8% -$9K 0.01% 1251
2021
Q1 		$146K Buy
+14,628
New +$154K 0.02% 963
2020
Q2 		– Sell
-21,428
Closed -$77K – 695
2020
Q1 		$77K Buy
+21,428
New +$121K 0.02% 929

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $935M AUM 298.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GSA Capital Partners's CRMD Position: Q4 2024 in Review

GSA Capital Partners sold out of CorMedix (CRMD) in Q4 2024, closing a stake of 11,825 shares — an estimated $96K sold.

GSA Capital Partners first reported a position in CRMD in Q1 2020 and held it in 14 quarters. The position peaked at $576K in Q4 2022. 129 funds tracked by Wall St. Rank hold CRMD as of Q4 2024.

  • GSA Capital Partners reported no remaining CorMedix position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 11,825 CorMedix shares in Q4 2024, an estimated $96K.
  • GSA Capital Partners first reported a position in CorMedix in Q1 2020 and held it in 14 quarters.
  • GSA Capital Partners's CorMedix position peaked at $576K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held CorMedix as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.